Author： Rita Kramer Powel Brown
Publisher： Adis International
ISSN： 0114-5916
Source： Drug Safety, Vol.27, Iss.13, 2004-01, pp. : 979-989
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Raloxifene: a STAR performer in breast cancer prevention?
Inpharma, Vol. 1, Iss. 1546, 2006-01 ,pp. :
Access to resources
Recommend
Celecoxib for skin cancer prevention?
Inpharma, Vol. 1, Iss. 1347, 2002-01 ,pp. :
Tamoxifen beyond 5 years the new path to prevention?
Inpharma, Vol. 1, Iss. 1620, 2008-01 ,pp. :
Should tocopherol, aspirin be laid to rest in CVD, cancer prevention?
Inpharma, Vol. 1, Iss. 1496, 2005-01 ,pp. :
Rofecoxib: potential in colorectal cancer prevention?
Inpharma, Vol. 1, Iss. 1278, 2001-01 ,pp. :